尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Anido Armando, 首席执行官. Insider active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. Aggregated, 12 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €20k. Activity tracked since 26 January 2022. The latest transaction was filed on 26 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
ANIDO ARMANDO is Président et Directeur Général. He has 12 filings in total. Across the 12 most recent filings available, the period runs from 2022-01-28 to 2026-06-30, with EUR 19506 of sales and EUR 0 of purchases; the companies mentioned are Zynerba Pharmaceuticals, Inc. and SCYNEXIS INC.